• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对遗传性和散发性溶血尿毒综合征的遗传学研究。

Genetic studies into inherited and sporadic hemolytic uremic syndrome.

作者信息

Warwicker P, Goodship T H, Donne R L, Pirson Y, Nicholls A, Ward R M, Turnpenny P, Goodship J A

机构信息

Department of Medicine, University of Newcastle upon Tyne, England, United Kingdom.

出版信息

Kidney Int. 1998 Apr;53(4):836-44. doi: 10.1111/j.1523-1755.1998.00824.x.

DOI:10.1111/j.1523-1755.1998.00824.x
PMID:9551389
Abstract

Hemolytic uremic syndrome (HUS) in adults carries a high morbidity and mortality, and its cause remains unknown despite many theories. Although familial HUS is rare, it affords a unique opportunity to elucidate underlying mechanisms that may have relevance to acquired HUS. We have undertaken a genetic linkage study based on a candidate gene approach. A common area bounded by the markers D1S212 and D1S306, a distance of 26 cM located at 1q32 segregated with the disease (Z max 3.94). We demonstrate that the gene for factor H lies within the region. Subsequent mutation analysis of the factor H gene has revealed two mutations in patients with HUS. In an individual with the sporadic/relapsing form of the disease we have found a mutation comprising a deletion, subsequent frame shift and premature stop codon leading to half normal levels of serum factor H. In one of the three families there is a point mutation in exon 20 causing an arginine to glycine change, which is likely to alter structure and hence function of the factor H protein. Factor H is a major plasma protein that plays a critical regulatory role in the alternative pathway of complement activation. In light of these findings and previous reports of HUS in patients with factor H deficiency, we postulate that abnormalities of factor H may be involved in the etiology of HUS.

摘要

成人溶血性尿毒症综合征(HUS)的发病率和死亡率很高,尽管有诸多理论,但病因仍不明。虽然家族性HUS罕见,但它为阐明可能与获得性HUS相关的潜在机制提供了独特机会。我们基于候选基因方法进行了一项基因连锁研究。由标记D1S212和D1S306界定的一个共同区域,位于1q32,距离为26厘摩,与该疾病共分离(Z最大值3.94)。我们证明补体因子H基因位于该区域内。随后对补体因子H基因的突变分析在HUS患者中发现了两个突变。在一名患有散发性/复发性疾病的个体中,我们发现了一个突变,包括一个缺失、随后的移码和过早的终止密码子,导致血清补体因子H水平为正常的一半。在三个家族中的一个家族中,外显子20存在一个点突变,导致精氨酸变为甘氨酸,这可能会改变补体因子H蛋白的结构,进而改变其功能。补体因子H是一种主要的血浆蛋白,在补体激活的替代途径中起关键调节作用。鉴于这些发现以及先前关于补体因子H缺乏患者发生HUS的报道,我们推测补体因子H异常可能参与了HUS的病因。

相似文献

1
Genetic studies into inherited and sporadic hemolytic uremic syndrome.对遗传性和散发性溶血尿毒综合征的遗传学研究。
Kidney Int. 1998 Apr;53(4):836-44. doi: 10.1111/j.1523-1755.1998.00824.x.
2
Familial haemolytic uraemic syndrome and an MCP mutation.家族性溶血性尿毒症综合征与MCP突变
Lancet. 2003 Nov 8;362(9395):1542-7. doi: 10.1016/S0140-6736(03)14742-3.
3
Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.与常染色体隐性非典型溶血尿毒综合征相关的补体因子H基因突变。
Am J Hum Genet. 1999 Dec;65(6):1538-46. doi: 10.1086/302673.
4
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.家族性溶血性尿毒症综合征的分子基础:补体因子H基因的突变分析揭示了短共有重复序列20中的一个热点。
J Am Soc Nephrol. 2001 Feb;12(2):297-307. doi: 10.1681/ASN.V122297.
5
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.溶血尿毒综合征中的补体因子H突变与基因多态性:C-257T、A2089G和G2881T多态性与该疾病密切相关。
Hum Mol Genet. 2003 Dec 15;12(24):3385-95. doi: 10.1093/hmg/ddg363. Epub 2003 Oct 28.
6
Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.非典型溶血性尿毒症综合征中因子H C末端区域错义突变的聚集
Am J Hum Genet. 2001 Feb;68(2):478-84. doi: 10.1086/318201. Epub 2001 Jan 17.
7
Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.家族性复发性溶血尿毒综合征与补体因子H缺乏症。
Nephrol Dial Transplant. 1999 May;14(5):1229-33. doi: 10.1093/ndt/14.5.1229.
8
Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.溶血尿毒综合征中的补体因子H突变集中在外显子18至20,这是一个对宿主细胞识别很重要的结构域。
Am J Hum Genet. 2001 Feb;68(2):485-90. doi: 10.1086/318203. Epub 2001 Jan 17.
9
Familial hemolytic-uremic syndrome and homozygous factor H deficiency.家族性溶血性尿毒症综合征与纯合子因子H缺乏症。
Am J Kidney Dis. 1994 Dec;24(6):936-41. doi: 10.1016/s0272-6386(12)81065-1.
10
The role of defective complement control in hemolytic uremic syndrome.补体控制缺陷在溶血性尿毒症综合征中的作用。
Semin Thromb Hemost. 2006 Mar;32(2):146-54. doi: 10.1055/s-2006-939770.

引用本文的文献

1
Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research.敌友之间:评估动物模型在推动补体研究临床突破方面的价值。
J Clin Invest. 2025 Jun 16;135(12). doi: 10.1172/JCI188347.
2
Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46.非典型溶血尿毒综合征:通过对补体调节蛋白CD46的分析对发病机制的遗传学见解
Ann Blood. 2023 Sep 30;8. doi: 10.21037/aob-22-40. Epub 2023 Apr 11.
3
Post-transplant Thrombotic Microangiopathy.
移植后血栓性微血管病
J Am Soc Nephrol. 2025 May 1;36(5):940-951. doi: 10.1681/ASN.0000000645. Epub 2025 Jan 31.
4
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum.国际肾脏病学会溶血尿毒综合征国际论坛的结果。
Kidney Int. 2024 Dec;106(6):1038-1050. doi: 10.1016/j.kint.2024.09.012. Epub 2024 Oct 10.
5
Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study.日本非典型溶血性尿毒症综合征管理的年度趋势及影响早期诊断和治疗的因素:一项回顾性研究。
Sci Rep. 2024 Aug 6;14(1):18265. doi: 10.1038/s41598-024-68736-6.
6
The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.补体系统在溶血尿毒综合征感染形式发病机制中的作用。
Biomolecules. 2023 Dec 27;14(1):39. doi: 10.3390/biom14010039.
7
Genetic investigation of Nordic patients with complement-mediated kidney diseases.北欧补体介导性肾脏疾病患者的遗传学研究。
Front Immunol. 2023 Sep 7;14:1254759. doi: 10.3389/fimmu.2023.1254759. eCollection 2023.
8
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.补体终末抑制时代的非典型溶血尿毒综合征:一项观察性队列研究。
Blood. 2023 Oct 19;142(16):1371-1386. doi: 10.1182/blood.2022018833.
9
Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system.蛋白类药物及其启示:在抑制补体系统的多蛋白级联反应时,要预料到意料之外的情况。
Immunol Rev. 2023 Jan;313(1):376-401. doi: 10.1111/imr.13164. Epub 2022 Nov 18.
10
The Factor H protein family: The switchers of the complement alternative pathway.补体旁路途径的开关:因子 H 蛋白家族。
Immunol Rev. 2023 Jan;313(1):25-45. doi: 10.1111/imr.13166. Epub 2022 Nov 16.